XML 62 R35.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 03, 2022
Dec. 07, 2021
Feb. 12, 2021
May 31, 2022
Aug. 31, 2021
May 31, 2021
Mar. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Feb. 11, 2021
Warrant term               5 years    
Amendment description pursuant to a Securities Purchase Agreement between the Company and the Purchasers dated as of April 28, 2022 (the “Purchase Agreement”), resulting in gross proceeds to the Company of approximately $17,000,000. The transaction was effected pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) promulgated thereunder                  
Sale of shares of common stock 2,991,669                  
Pre-Funded Warrants Exercise price               $ 0.0001    
Purchase of warrants shares 4,563,887                  
Purchase of Pre-Funded Warrant and related Common Warrant 15,111,112                  
Common warrants exercise price               $ 2.00    
Combined offering price of Pre-Funded Warrant and related Common Warrant $ 2.25                  
Private Offering [Member]                    
Warrants to purchase shares of common stock       4,563,887            
Series B Convertible Preferred Stock [Member]                    
Proceeds from issuance of preferred stock     $ 326,600              
Issuance of preferred stock     350             350
Preferred stock par value                   $ 0.001
Preferred stock stated value                   $ 1,200
Redeemedation of preferred stock         120.00%          
Additional shares of common stock     3,000              
Series C Convertible Preferred Stock [Member]                    
Preferred stock purchase price             $ 150,000      
Proceeds from issuance of preferred stock             $ 141,049      
Issuance of preferred stock             150      
Preferred stock par value             $ 0.001      
Preferred stock stated value             $ 1,200      
Redeemedation of preferred stock         120.00%          
Roth Capital Partners [Member]                    
Paid placement agent fee               $ 1,360,000    
Issued warrant to purchase shares of common stock               1,133,333    
Measurement Input Exercise Price [Member] | Maximum [Member]                    
Sale of shares of common stock   3,875,000                
Purchase of warrants shares   3,875,000                
Warrant exercise price   $ 4.13                
Common stock exercise price   $ 4.13                
Gross proceeds   $ 16,003,750                
Bridge Notes reduced   $ 4.13                
Revaluation [Member] | Measurement Input Price Volatility [Member] | Warrant [Member]                    
Warrant exercise price                 $ 15.00  
Shares issued upon exercise of warrants, shares                 30,000  
Warrant term                 10 years  
Warrants [Member]                    
Warrants to purchase shares of common stock       16,244,445            
Purchase of warrants shares         383,235 28,020     5,191,365  
Warrant exercise price       $ 2.00 $ 4.13       $ 4.13  
Purchase of anti-dilution warrants shares         932,104          
Warrant anti-dilution exercise price         $ 4.13          
Class of Warrant or Right, Outstanding               22,969,266 6,604,820  
Class of warrant or right converted into common shares                 43,167  
Warrants [Member] | Maximum [Member]                    
Warrant exercise price           $ 15.00        
Warrants [Member] | Minimum [Member]                    
Warrant exercise price           $ 14.00